Literature DB >> 11809774

Oxidative stress is markedly elevated in lecithin:cholesterol acyltransferase-deficient mice and is paradoxically reversed in the apolipoprotein E knockout background in association with a reduction in atherosclerosis.

Dominic S Ng1, Graham F Maguire, John Wylie, Amir Ravandi, Wanli Xuan, Zakaria Ahmed, Mohammad Eskandarian, Arnis Kuksis, Philip W Connelly.   

Abstract

Complete lecithin:cholesterol acyltransferase (LCAT) deficiency is a rare cause of severe hypoalphalipoproteinemia, but the affected subjects are surprisingly not particularly prone to premature coronary heart disease. We studied oxidative stress in lcat-/- mice and their cross-breed with apolipoprotein-E knockout mice (apoE-/-xlcat-/-) by measuring vascular ring superoxide production and plasma phospholipid (PL)-bound F2-isoprostane levels and their relationship with aortic atherosclerosis. Compared with wild type control (lcat+/+), lcat-/- and lcat+/- mice showed a 4.9- (p = 0.003) and a 2.1-fold (p = 0.04) increase in plasma PL-F2-isoprostane levels, respectively. There was also a 3.6- (p < 0.0001) and 2.9-fold (p = 0.003) increase in the area under the curve for the aortic ring superoxide excursion by lucigenin-derived chemiluminescence. A comparison of apoE-/-xlcat+/+ mice with wild type control mice showed a more modest 2.1- (p = 0.04) and 2.2-fold (p < 0.00001) increase in these respective markers. Surprisingly, the apoE-/-xlcat-/- mice showed a paradoxical normalization in both oxidation markers. Furthermore, by fast protein liquid chromatography separation, we observed an associated retention and redistribution of serum paraoxonase activities to the non-high density lipoprotein fractions in both the apoE-/-xlcat-/- and apoE-/-xlcat+/- mice. Aortic atherosclerotic lesions in male apoE-/-xlcat-/- and apoE-/-xlcat+/- mice were reduced by 52 (p = 0.02) and 24% (p = 0.46), respectively. Our data suggest that LCAT-deficient mice are associated with an increased oxidative stress that is paradoxically reversed in a hyperlipidemic background, possibly due to the redistribution of paraoxonase. This modulation of oxidative stress may in part contribute to the reduced atherosclerosis seen in the apoE-/- xlcat-/- mice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11809774     DOI: 10.1074/jbc.M112320200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Lecithin: cholesterol acyltransferase expression has minimal effects on macrophage reverse cholesterol transport in vivo.

Authors:  Hiroyuki Tanigawa; Jeffrey T Billheimer; Jun-ichiro Tohyama; Ilia V Fuki; Dominic S Ng; George H Rothblat; Daniel J Rader
Journal:  Circulation       Date:  2009-06-29       Impact factor: 29.690

2.  Diet-induced lipid accumulation in phospholipid transfer protein-deficient mice: its atherogenicity and potential mechanism.

Authors:  Calvin Yeang; Shucun Qin; Kailian Chen; David Q-H Wang; Xian-Cheng Jiang
Journal:  J Lipid Res       Date:  2010-06-11       Impact factor: 5.922

3.  Lecithin:cholesterol acyltransferase deficiency protects against cholesterol-induced hepatic endoplasmic reticulum stress in mice.

Authors:  Lauren Hager; Lixin Li; Henry Pun; Lu Liu; Mohammad A Hossain; Graham F Maguire; Mark Naples; Chris Baker; Lilia Magomedova; Jonathan Tam; Khosrow Adeli; Carolyn L Cummins; Philip W Connelly; Dominic S Ng
Journal:  J Biol Chem       Date:  2012-04-12       Impact factor: 5.157

4.  Clinical Implications of Lipid Genetics for Cardiovascular Disease.

Authors:  Alanna Strong; Daniel J Rader
Journal:  Curr Cardiovasc Risk Rep       Date:  2010-10

5.  Lecithin cholesterol acyltransferase null mice are protected from diet-induced obesity and insulin resistance in a gender-specific manner through multiple pathways.

Authors:  Lixin Li; Mohammad A Hossain; Sabreena Sadat; Lauren Hager; Lu Liu; Laetitia Tam; Stephanie Schroer; Lu Huogen; I George Fantus; Philip W Connelly; Minna Woo; Dominic S Ng
Journal:  J Biol Chem       Date:  2011-03-16       Impact factor: 5.157

Review 6.  Lecithin cholesterol acyltransferase: an anti- or pro-atherogenic factor?

Authors:  Xavier Rousset; Robert Shamburek; Boris Vaisman; Marcelo Amar; Alan T Remaley
Journal:  Curr Atheroscler Rep       Date:  2011-06       Impact factor: 5.113

7.  A novel in vivo lecithin-cholesterol acyltransferase (LCAT)-deficient mouse expressing predominantly LpX is associated with spontaneous glomerulopathy.

Authors:  Xianghong Zhu; Andrew M Herzenberg; Mohammad Eskandarian; Graham F Maguire; James W Scholey; Philip W Connelly; Dominic S Ng
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

8.  Lecithin: cholesterol acyltransferase and atherosclerosis: another high-density lipoprotein story that doesn't quite follow the script.

Authors:  Daniel J Rader
Journal:  Circulation       Date:  2009-08-03       Impact factor: 29.690

Review 9.  HDL Cholesterol Metabolism and the Risk of CHD: New Insights from Human Genetics.

Authors:  Cecilia Vitali; Sumeet A Khetarpal; Daniel J Rader
Journal:  Curr Cardiol Rep       Date:  2017-11-04       Impact factor: 2.931

Review 10.  Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?

Authors:  Sandra Kunnen; Miranda Van Eck
Journal:  J Lipid Res       Date:  2012-05-07       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.